Small Molecule Drug Discovery Market remains a cornerstone of pharmaceutical R&D, driven by the need for new treatments for a wide range of diseases. Despite the rise of biologics, small molecules offer advantages like oral bioavailability and ability to target intracellular components. Advances in technologies like high-throughput screening, fragment-based drug design, and AI-powered computational chemistry are key drivers.The market is seeing a trend towards the discovery of targeted covalent inhibitors and drugs that modulate protein-protein interactions, as well as the use of DNA-encoded libraries (DELs) for hit generation. Key players include major pharmaceutical companies like Pfizer, Novartis, and Merck, as well as specialized CROs like Charles River and Evotec. The integration of AI and machine learning is significantly accelerating early-stage discovery and reducing costs.
Other Related Reports:www.marketresearchfuture.com/reports/medical-billing-market-1023
www.marketresearchfuture.com/reports/medical-electrode-market-27634
www.marketresearchfuture.com/reports/medical-linear-accelerator-market-27614
www.marketresearchfuture.com/reports/medical-second-opinion-market-9701
www.marketresearchfuture.com/reports/menstrual-cup-market-1407
www.marketresearchfuture.com/reports/metabolic-syndrome-market-27832
www.marketresearchfuture.com/reports/nano-healthcare-technology-medical-equipment-market-33607
www.marketresearchfuture.com/reports/nasal-spray-market-19227
www.marketresearchfuture.com/reports/online-doctor-consultation-market-42974